SelectScience
Join Free
NewsLife Sciences

QIAGEN forms Lung Cancer Expert Alliance

QIAGEN

Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS

2 Jun 2016
Alex Waite
Editorial Assistant

Industry news

QIAGEN has announced the formation of a global consortium of international lung cancer experts who will advise the company on the design of new next-generation sequencing (NGS) gene panels and associated workflows that target lung cancer-specific mutations.

The members of the consortium will work with a QIAGEN team to guide selection of the genes and variants for the panels, development of the NGS workflows, and the verification of both the panels and workflows. The results of these validation studies will be published by the Expert Alliance. From the work of the consortium, QIAGEN will deliver a series of Sample to Insight lung cancer NGS panel workflows for use with both tissue and liquid biopsy samples on QIAGEN’s GeneReader NGS System, the world’s first truly complete NGS workflow – from Sample to Insight.


The founding collaborators of the Alliance include:

  • Marc Denis, Pharm.D., Ph.D., professor of biochemistry and molecular biology at Nantes University Hospital, Nantes, France
  • Prof. Dr. med. Manfred Dietel, Institute for Anatomic Pathology and of Charité, Humboldt-University of Berlin, Berlin, Germany
  • Helen (D’Silva) Fernandes, Ph.D., associate professor of pathology and laboratory medicine, solid tumor section laboratory, Weill Cornell Medical School, New York Presbyterian Hospital, New York, New York
  • Jesús García Foncillas, director of the Cancer Institute, University Hospital Network, University Hospital “Fundación Jiménez Díaz,” Madrid, Spain
  • Henrik Hager, M.D., Ph.D., consultant pathologist and associate clinical professor, Aarhus University Hospital, Aarhus, Denmark
  • Nicola Normanno, M.D., director of the Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy
  • Santiago Ramon y Cajal, M.D., Ph.D., chairman of the pathology department, Vall d’Hebron University Hospital, Barcelona, Spain
  • Philippe Tanière, M.D., Ph.D., consultant pathologist, Queen Elizabeth Hospital and honorary senior lecturer at the Medical School, Birmingham, England

“I am delighted to join QIAGEN’s consortium of lung cancer experts to help tackle the many challenges in lung cancer research through NGS,” said Dr. Nicola Normanno, director of the Department of Experimental Oncology at the INT-Fondazione Pascale in Naples, Italy. “NGS is providing us with new opportunities by targeting individual genes and mutations that are associated with a particular kind of cancer. I look forward to working with renowned colleagues from around the world to advance the use of this revolutionary technology in lung cancer research.”

Lung cancer is the number one cancer killer in the world, according to the World Health Organization. The disease causes nearly 1.6 million deaths a year.

“We are grateful to the charter members of our lung cancer Expert Alliance for sharing our commitment to improving the understanding of the underlying causes of this terrible disease,” said Thierry Bernard, Senior Vice President and Head of QIAGEN’s Business Area Molecular Diagnostics. “Their work will benefit future patients – and add to our growing pipeline of lung cancer panels running on our GeneReader NGS System. This includes a panel for detection and analysis of genetic copy number variations from tissue and blood as well as an “All-in-One” lung cancer panel that adds gene fusions to its coverage of actionable variants.”

Since its introduction in late 2015, the GeneReader NGS System has gained widespread recognition as a complete Sample to Insight workflow solution. The system helps users overcome the workflow, data analysis and entry cost problems associated with other systems.

QIAGEN will demonstrate its Sample to Insight solutions for molecular diagnostic and research applications in oncology at Booth 18031 at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting on June 3-7, 2016, in Chicago.

Links

QIAGENCompany website

Tags

Sample PreparationSample preparation can improve the quality and speed of separation techniques. Products to assist sample preparation include filtration equipment, evaporators, membranes and sieves.Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.DNA / RNA Extraction and PurificationPurified DNA and RNA are required for numerous downstream molecular biology applications. Consequently, the importance of high-quality DNA/RNA extraction and purification equipment cannot be underestimated. Many purification kits are available and are typically optimized for nucleic acid type and source, including plasmid DNA, genomic DNA, mRNA, RNA and viral nucleic acid purification kits. Automated extraction and purification of nucleic acids can be implemented with magnetic bead separator instruments or high-throughput purification workstations. Find the best DNA/RNA extraction and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.DNA SequencingDNA sequencing, such as sanger sequencing, is a biological technique that determines the precise order of nucleotide bases in a fragment or template of DNA. DNA sequencers and genetic analyzers are based on capillary electrophoresis, where labeled DNA fragments are electrophoretically separated by size as they migrate through a polymer. Find the best DNA sequencing products, including DNA sequencing kits, genomic libraries and genetic identity kits in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Gene Expression and Molecular CloningMolecular cloning is a set of techniques that utilizes vectors to transfer recombinant DNA into host cells and is an essential tool for investigating the expression of genes and proteins in bacterial or mammalian cells. A variety of vectors optimized for gene cloning and expression in a range of host organisms are available, alongside competent cells for genetic replication. Here, you can explore a range of molecular tools, high-quality genomic and cDNA libraries, premade clones, transformation and transfection reagents and mutagenesis or gene expression detection assays and expression arrays. Find the best gene expression and molecular cloning products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Automated Liquid HandlingAutomated liquid handling equipment is used to mix, dilute and dispense allotted volumes of liquid into microplates and other vessels automatically. The robotic, liquid handling arms can dispense from single channel to 3456 multichannel as well as operate nanoliter dispensing, enabling high throughput of samples. Find the best automated liquid handlers in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Development SoftwareComputational techniques used in both the chemistry and biology aspects of drug development, for data acquisition, data analysis, processing and storage. Software is used for analysis of ADME results, toxicology, clinical trials and regulatory processes. RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Cancer DiagnosticsThere are a wide variety of diagnostic tests for cancer available, and this range continues to expand as our knowledge of cancer improves. Current diagnostic methods include biopsy, imaging and blood tests for known biomarkers. New methods in research development include liquid biopsies and cancer breathalyzers.Gene Expression

Related articles

QIAGEN forms Lung Cancer Expert Alliance